QuidelOrtho Stock Plummets on Weak Revenue Guidance

Revenue Guidance Misses Wall Street Estimates

QuidelOrtho Corporation (NASDAQ:QDEL) shares experienced a sharp decline of 21% in after-hours trading. The drop followed the company's release of preliminary first-quarter revenue guidance, projected to be between $615 million and $620 million, falling significantly short of the Wall Street consensus of $679.59 million.

Factors Behind the Shortfall

The diagnostics company attributed the revenue miss to several factors. A primary cause was a weaker-than-expected respiratory season, with U.S. Influenza-like Illness visits down approximately 30% from the prior year. Additionally, the company cited slower distributor sales in China, potentially linked to proposed reimbursement rate cuts, and delays of certain orders in Europe, the Middle East, and Africa due to regional conflict.

Impact on Financials and Company Response

For the first quarter, QuidelOrtho anticipates a negative free cash flow in the range of $65 million to $70 million. Despite the near-term challenges, CEO Brian J. Blaser emphasized that the core business remains strong. He stated that the company is actively implementing cost-reduction measures to enhance its full-year performance for 2026.

Summary and Outlook

The negative forecast triggered a significant sell-off in QDEL shares. Investors will be closely monitoring the company's complete first-quarter financial results, scheduled for release after the market closes on Tuesday, May 5, 2026. These results will provide further insight into the company's strategy for navigating the current macroeconomic headwinds.

FAQ

Q: Why did QuidelOrtho's stock price fall sharply?
A: The stock fell over 20% after the company issued first-quarter revenue guidance that was significantly below analyst expectations.

Q: What were the main reasons for the weak guidance?
A: The company cited a mild respiratory season, slower sales in China, and geopolitical conflict-related order delays in the EMEA region.

Q: When will QuidelOrtho release its full financial results?
A: The company plans to release its complete first-quarter 2026 results on May 5, 2026.

Source: Investing.com